Nhan Trung Vo

Dr. Nhan Trung Vo

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
NVNhan Trung Vo
Nhan Trung Vo
HSHae Eun Shin
Hae Eun Shin
YKYeji Kim
Yeji Kim
In Bo HanIn Bo Han
In Bo Han
Spinal cord injury (SCI) is a devastating neurological disorder that can result in permanent disability and reduced quality of life, characterized by heterogeneous injury mechanisms and limited tools for accurate early diagnosis and prognostic stratification. The clinical course of SCI is driven not only by the initial mechanical insult but also by complex secondary injury cascades involving neuroinflammation, axonal degeneration, demyelination, and maladaptive repair responses. Current diagnostic and prognostic approaches, which rely largely on neurological examination and imaging, provide limited insight into these dynamic molecular processes. In this context, extracellular vesicles (EVs) have emerged as a biologically compelling source of biomarkers for SCI. EVs are released by neurons, glial cells, endothelial cells, and immune cells and carry molecular cargo that reflects cellular stress, injury severity, and endogenous repair activity. Increasing evidence indicates that EV-associated proteins and regulatory microRNAs (miRNAs) encode injury-specific signatures related to neuronal and glial damage, inflammatory signaling, metabolic stress, and functional recovery potential. In this review, we summarize the current knowledge on EV biology in SCI and discuss emerging evidence supporting EV-derived proteins and miRNAs as promising tools for refining diagnosis and prognosis. Our aim is not only to consolidate established findings but also to highlight EV-based molecular signatures as a developing framework for precision biomarker discovery in SCI.

Verified
Journal Article
Open access
PDF file
VBVy Phuong Bui
Vy Phuong Bui
VTVang Pham Thi
Vang Pham Thi
NVNhan Trung Vo
Nhan Trung Vo
VNViet-Trinh Nguyen
Viet-Trinh Nguyen
DTDuong Tran Thai
Duong Tran Thai
MTMinh-Dung Truong
Minh-Dung Truong
(1) Background: Knee cartilage injury is at the top of the rising concerns among bone and joint disorder patients. Autologous chondrocyte implantation (ACI) is widely used to approach knee cartilage deterioration. Integrating autologous chondrocytes and periosteal patches aids in forming new cartilage-like tissue at the lesion area. This study uses a novel cell source from one-day-old porcine cartilage to fabricate a biomembrane as a substitute for periosteal membranes in cell implantation techniques for treating knee cartilage injuries. (2) Methods: Cells isolated from one-day-old porcine cartilage tissue were identified and assessed for their proliferation capability, differentiation ability, and membrane formation potential. The protein component of the biomembrane was also defined by proteomics. The cartilage repair ability was also confirmed using an in vitro transplantation model. (3) Results: Negative results for porcine infectious diseases are pivotal in selecting suitable piglets to provide cartilage tissue. The cells successfully obtained from one-day-old porcine cartilage exhibited stem-cell-like characteristics (CD34-, CD45-, CD90+, CD105+), including a high proliferation to 20 passages (doubling time: 1–2 days) and a capacity to differentiate into various cell types (osteogenesis, adipogenesis, and chondrogenesis). The stem cells were successfully applied in the fabrication of the biomembranes. The protein components of the biomembrane included an extracellular matrix and growth factors. The in vitro transplantation model showed that the biomembrane induced the repair ability of cartilage defects. (4) Conclusions: This study is the first to successfully harvest stem cells from one-day-old porcine cartilage for biomembrane fabrication for a knee cartilage injury therapeutic application.

28 January 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
VBVy Phuong Bui
Vy Phuong Bui
VTVang Pham Thi
Vang Pham Thi
NVNhan Trung Vo
Nhan Trung Vo
VNViet-Trinh Nguyen
Viet-Trinh Nguyen
DTDuong Tran Thai
Duong Tran Thai
MTMinh-Dung Truong
Minh-Dung Truong
(1) Background: Knee cartilage injury is at the top of the rising concerns among bone and joint disorders patients. Autologous chondrocyte implantation (ACI) is widely used to approach knee cartilage deterioration. Integrating autologous chondrocytes and periosteal patches aids in forming new cartilage-like tissue at the lesion area. This study uses a novel cell source from one-day-old porcine cartilage to fabricate a bio-membrane as a substitute for periosteal membranes in cell implantation techniques for treating knee cartilage injuries. (2) Methods: Cells isolated from one-day-old porcine cartilage tissue were identified and assessed for their proliferation capability, differentiation ability, and membrane formation potential. The protein component of bio-membrane also was defined by proteomics. Cartilage repair ability was also confirmed using an in vitro transplantation model. (3) Results: Negative results for porcine infectious diseases are pivotal in selecting suitable piglets to provide cartilage tissue. Cells successfully obtained from one-day-old porcine cartilage exhibited stem cell-like characteristics (CD34-, CD45-, CD90+, CD105+), including high proliferation to 20 passages (doubling time: 1-2 days) and differentiation capacity into various cell types (osteogenesis, adipogenesis, chondrogenesis). Stem cells were successfully applied in the fabrication of bio-membranes. The protein components of bio-membrane included extracellular matrix and growth factors. The in vitro transplantation model showed that bio-membrane induced the repair ability of cartilage defects. (4) Conclusions: This study is the first to successfully harvest stem cells from one-day-old porcine cartilage for bio-membrane fabrication in knee cartilage injury therapeutic application.